Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -41.28% vs -20.04% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 13.91% vs -3.52% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 10.00% vs 0.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -24.45% vs -10.67% in Mar 2025
Compare Balance Sheet Results of Beryl Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.09
5.92
-0.83
-14.02%
Share Warrants & Outstandings
Total Reserve
4.79
7.37
-2.58
-35.01%
Shareholder's Funds
9.89
13.29
-3.40
-25.58%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
2.80
-2.80
-100.00%
Secured Loans
0.00
0.26
-0.26
-100.00%
Unsecured Loans
0.00
2.54
-2.54
-100.00%
Deferred Tax Assets / Liabilities
0.04
0.00
0.04
0.00%
Other Long Term Liabilities
0.05
0.44
-0.39
-88.64%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.51
0.00
0.51
0.00%
Total Non-Current Liabilities
0.60
3.24
-2.64
-81.48%
Current Liabilities
Trade Payables
1.43
4.04
-2.61
-64.60%
Other Current Liabilities
0.51
0.06
0.45
750.00%
Short Term Borrowings
2.39
0.00
2.39
0.00%
Short Term Provisions
0.15
0.27
-0.12
-44.44%
Total Current Liabilities
4.48
4.36
0.12
2.75%
Total Liabilities
14.96
20.89
-5.93
-28.39%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
14.94
14.48
0.46
3.18%
Less: Accumulated Depreciation
8.39
6.28
2.11
33.60%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
6.55
8.20
-1.65
-20.12%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
1.39
-1.39
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.22
0.05
0.17
340.00%
Long Term Loans & Advances
0.19
0.01
0.18
1,800.00%
Other Non Current Assets
0.91
0.38
0.53
139.47%
Total Non-Current Assets
8.13
10.03
-1.90
-18.94%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.13
0.25
2.88
1,152.00%
Sundry Debtors
2.09
9.18
-7.09
-77.23%
Cash and Bank
0.27
0.15
0.12
80.00%
Other Current Assets
1.01
0.00
1.01
0.00%
Short Term Loans and Advances
0.33
1.28
-0.95
-74.22%
Total Current Assets
6.83
10.85
-4.02
-37.05%
Net Current Assets (Including Current Investments)
2.35
6.50
-4.15
-63.85%
Total Current Assets Excluding Current Investments
6.83
10.85
-4.02
-37.05%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
14.96
20.89
-5.93
-28.39%
Contingent Liabilities
0.30
0.00
0.30
0.00%
Total Debt
2.39
2.80
-0.41
-14.64%
Book Value per share (adjusted)
19.41
22.34
-2.93
-13.12%
Annual - Borrowings
Borrowings 2.39 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -41.28% vs -20.04% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 6.55 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.91% vs -3.52% in Mar 2025
Annual - Investments
Investments 0.22 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.00% vs 0.00% in Mar 2025
Annual - Current Assets
Current Assets 6.83 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -24.45% vs -10.67% in Mar 2025